Mitochondrial Metabolism Disease, also known as abnormality of mitochondrial metabolism, is related to mitochondrial disease and mitochondrial complex iii deficiency, nuclear type 2. An important gene associated with Mitochondrial Metabolism Disease is SLC25A4 (Solute Carrier Family 25 Member 4), and among its related pathways/superpathways are Metabolism and Peroxisomal lipid metabolism. The drugs Atorvastatin and Enzyme Inhibitors have been mentioned in the context of this disorder. Affiliated tissues include placenta and skeletal muscle, and related phenotypes are homeostasis/metabolism and growth/size/body region